EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic and Selective Antiproliferative Effects of Cafestol and a Hyaluronic Acid–Epigallocatechin Gallate Conjugate in Human Renal Cancer Cells

Nunnarpas Yongvongsoontorn iD, Yudo Sawa, Atsushi Yamashita, Joo Eun Chung iD, Kaoru Hiratsuka iD, Koji Izumi iD, Hiroaki Iwamoto iD, Motoichi Kurisawa iD

International Journal of Molecular Sciences · 29.05.2026 · 27 (11) · 4929

DOI: 10.3390/ijms27114929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.05.2026. Verfasst von Nunnarpas Yongvongsoontorn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, 1-1 Asahidai, Nomi 923-1292, Ishikawa, Japan. Hauptthemen laut MEDLINE: Catechin, Hyaluronic Acid, Kidney Neoplasms, Antineoplastic Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS Program for Forming Japan's Peak Research Universities(J-PEAKS), JSPS Program for Forming Japan’s Peak Research Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cancer remains a major global health burden, and current targeted and immunotherapeutic strategies are frequently limited by toxicity, therapeutic resistance, and suboptimal response rates. Natural bioactive compounds such as epigallocatechin gallate (EGCG) and cafestol exhibit anticancer activity; however, their therapeutic utility is constrained by limited potency and dose-dependent adverse effects. In this study, the antiproliferative and synergistic effects of cafestol and a hyaluronic acid (HA)–EGCG conjugate were investigated in renal cancer cells. HA conjugation significantly enhanced the antiproliferative efficacy of EGCG in both ACHN and A498 human renal cancer cells, whereas unmodified HA exhibited no intrinsic anticancer activity. Importantly, the HA–EGCG conjugate enabled a pronounced synergistic interaction with cafestol, particularly in ACHN cells, as confirmed by combination index analysis, while free EGCG and cafestol failed to achieve synergistic inhibition. In addition, the HA–EGCG conjugate and its combination with cafestol exhibited favorable selectivity toward renal cancer cells compared with normal renal proximal tubule epithelial cells (RPTECs). This combination robustly enhanced apoptosis and was associated with significant downregulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL at the transcriptional level, together with suppression of the epithelial–mesenchymal transition-associated transcription factor SNAIL at both transcriptional and protein levels. Notably, the enhanced antiproliferative effects were achieved at reduced concentrations, highlighting the potential to mitigate dose-related toxicity. Collectively, these findings support HA-based conjugation as an effective strategy to potentiate the anticancer activity of natural bioactive compounds and to enable synergistic, multi-targeted therapeutic effects against renal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatechinHyaluronic AcidKidney NeoplasmsAntineoplastic AgentsHumansCell ProliferationDrug SynergismCell Line, TumorApoptosis

Stichwörter der Autor:innen

cafestolcombination index (CI)epigallocatechin gallate (EGCG)hyaluronic acidpolymer conjugaterenal cell carcinomasynergistic effects

Substanzen

Catechinepigallocatechin gallateHyaluronic AcidAntineoplastic Agents

Autor:innen und Institutionen

  • Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, 1-1 Asahidai, Nomi 923-1292, Ishikawa, Japan.
  • Integrative Cancer Therapy and Urology, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

ORCID-Profile: Nunnarpas Yongvongsoontorn, Joo Eun Chung, Kaoru Hiratsuka, Koji Izumi, Hiroaki Iwamoto, Motoichi Kurisawa

Förderung

  • JSPS Program for Forming Japan's Peak Research Universities(J-PEAKS)
  • JSPS Program for Forming Japan’s Peak Research Universities

Zitieren

APA

Yongvongsoontorn, N., Sawa, Y., Yamashita, A., Chung, J. E., Hiratsuka, K., Izumi, K., Iwamoto, H., & Kurisawa, M. (2026). Synergistic and Selective Antiproliferative Effects of Cafestol and a Hyaluronic Acid–Epigallocatechin Gallate Conjugate in Human Renal Cancer Cells. International Journal of Molecular Sciences, 27(11), 4929. https://doi.org/10.3390/ijms27114929

Vancouver

Yongvongsoontorn N, Sawa Y, Yamashita A, Chung JE, Hiratsuka K, Izumi K, et al. Synergistic and Selective Antiproliferative Effects of Cafestol and a Hyaluronic Acid–Epigallocatechin Gallate Conjugate in Human Renal Cancer Cells. International Journal of Molecular Sciences. 2026;27(11):4929. doi:10.3390/ijms27114929

BibTeX
@article{Yongvongsoontorn2026,
  author = {Yongvongsoontorn, Nunnarpas and Sawa, Yudo and Yamashita, Atsushi and Chung, Joo Eun and Hiratsuka, Kaoru and Izumi, Koji and Iwamoto, Hiroaki and Kurisawa, Motoichi},
  title = {Synergistic and Selective Antiproliferative Effects of Cafestol and a Hyaluronic Acid–Epigallocatechin Gallate Conjugate in Human Renal Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {4929},
  doi = {10.3390/ijms27114929}
}
Kostenlos starten →